Whitehawk Therapeutics (WHWK) Competitors

Tonix Pharmaceuticals (NASDAQ:TNXP) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Does the media prefer TNXP or WHWK?

In the previous week, Tonix Pharmaceuticals had 10 more articles in the media than Whitehawk Therapeutics. MarketBeat recorded 14 mentions for Tonix Pharmaceuticals and 4 mentions for Whitehawk Therapeutics. Tonix Pharmaceuticals' average media sentiment score of 0.21 beat Whitehawk Therapeutics' score of 0.10 indicating that Tonix Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tonix Pharmaceuticals	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Whitehawk Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in TNXP or WHWK?

82.3% of Tonix Pharmaceuticals shares are held by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 0.0% of Tonix Pharmaceuticals shares are held by insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is TNXP or WHWK more profitable?

Whitehawk Therapeutics has a net margin of 99.42% compared to Tonix Pharmaceuticals' net margin of -828.22%. Tonix Pharmaceuticals' return on equity of -57.93% beat Whitehawk Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tonix Pharmaceuticals	-828.22%	-57.93%	-51.04%
Whitehawk Therapeutics	99.42%	-75.99%	-68.57%

Do analysts prefer TNXP or WHWK?

Tonix Pharmaceuticals presently has a consensus target price of $70.00, indicating a potential upside of 15.04%. Given Tonix Pharmaceuticals' stronger consensus rating and higher probable upside, equities research analysts clearly believe Tonix Pharmaceuticals is more favorable than Whitehawk Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tonix Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Whitehawk Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better earnings and valuation, TNXP or WHWK?

Whitehawk Therapeutics has higher revenue and earnings than Tonix Pharmaceuticals. Whitehawk Therapeutics is trading at a lower price-to-earnings ratio than Tonix Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tonix Pharmaceuticals	$10.09M	52.89	-$130.04M	-$1.96 thousand	-0.03
Whitehawk Therapeutics	$21.60M	3.64	-$63.69M	-$0.06	-27.83

Which has more risk & volatility, TNXP or WHWK?

Tonix Pharmaceuticals has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.

Summary

Tonix Pharmaceuticals beats Whitehawk Therapeutics on 11 of the 16 factors compared between the two stocks.